Gains May Be On The Menu For Ambev S.A. ADR (NYSE: ABEV)

Currently, there are 15.75B common shares owned by the public and among those 15.75B shares have been available to trade.

The company’s stock has a 5-day price change of -0.40% and -12.68% over the past three months. ABEV shares are trading -11.43% year to date (YTD), with the 12-month market performance down to -5.93% lower. It has a 12-month low price of $2.29 and touched a high of $3.06 over the same period. ABEV has an average intraday trading volume of 11.14 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.14%, -3.73%, and -6.95% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of Ambev S.A. ADR (NYSE: ABEV) shares accounts for 8.56% of the company’s 15.75B shares outstanding.

It has a market capitalization of $39.06B and a beta (3y monthly) value of 1.11. The stock’s trailing 12-month PE ratio is 13.52, while the earnings-per-share (ttm) stands at $0.18. The company has a PEG of 2.05 and a Quick Ratio of 0.66 with the debt-to-equity ratio at 0.04. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.47% over the week and 1.74% over the month.

Analysts forecast that Ambev S.A. ADR (ABEV) will achieve an EPS of $0.04 for the current quarter, $0.03 for the next quarter and $0.19 for 2025. The lowest estimate earnings-per-share for the quarter is $0.03 while analysts give the company a high EPS estimate of $0.05. Comparatively, EPS for the current quarter was $0.04 a year ago. Earnings per share for the fiscal year are expected to decrease by -4.81%, and 9.99% over the next financial year. EPS should grow at an annualized rate of 6.60% over the next five years, compared to -0.78% over the past 5-year period.

Looking at the support for the ABEV, a number of firms have released research notes about the stock. Barclays stated their Equal Weight rating for the stock in a research note on March 04, 2024, with the firm’s price target at $3.50-$3. Jefferies on their part issued Hold rating on November 22, 2023.

Most Popular

Related Posts